Drug Pipeline

Lisocabtagene Maraleucel Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
11
Active Studies
8
Recruiting
1
Phase 3
9
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-11 NCT07015242
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line…		 Trial sites reduced: 82 -> 40 locations
Active Studies by Phase
Phase 3
1
Phase 2
6
Phase 1/2
2
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07188558 A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy Large B-cell Lymphoma Recruiting
Phase 2
NCT05633615 Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory… Diffuse Large B-Cell Lymphoma Recruiting
NCT05873712 Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome Recurrent Transformed Chronic Lymphocytic Leukemia Recruiting
NCT07194980 Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory… Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recruiting
NCT07015242 A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line… Lymphoma Recruiting
NCT05583149 Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas Refractory Aggressive B-cell Lymphomas Active, Not Recruiting
NCT05672173 Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's… Recurrent Transformed Chronic Lymphocytic Leukemia Active, Not Recruiting
Phase 1/2
NCT07098364 ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in… Recurrent Diffuse Large B-Cell Lymphoma Recruiting
NCT03331198 Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory… Leukemia, Lymphocytic, Chronic, B-Cell Recruiting
Phase 1
NCT05359211 NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or… Recurrent Diffuse Large B-Cell Lymphoma Active, Not Recruiting
Not specified
NCT06357754 Transgene Assay Testing Service of Tumor Samples From Patients Who Received a… Non-Hodgkin Lymphoma Recruiting
Sponsors Running Lisocabtagene Maraleucel Trials
Fred Hutchinson Cancer Center (3) Juno Therapeutics, a Subsidiary of Celgene (1) Patrick C. Johnson, MD (1) SWOG Cancer Research Network (1) City of Hope Medical Center (1) Aseel Alsouqi (1) Bristol-Myers Squibb (1) Juno Therapeutics, Inc., a Bristol-Myers Squibb Company (1) Lyell Immunopharma, Inc. (1)
Disease Areas
Non-Hodgkin Lymphoma (6) DLBCL (6) Leukemia (5) Follicular Lymphoma (4) Chronic Lymphocytic Leukemia (CLL) (4) Multiple Myeloma (1)
Get alerts when Lisocabtagene Maraleucel trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free